Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 26499888)

Published in Mol Med Rep on October 13, 2015

Authors

Sen-Lin Ma1, Ai-Jun Li1, Zhao-Yang Hu2, Fu-Sheng Shang3, Meng-Chao Wu1

Author Affiliations

1: Department of Second Special Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, P.R. China.
2: Tumor Research Institute, Hangzhou Cancer Hospital, Hangzhou, Zhejiang 310002, P.R. China.
3: Department of Experiments, Shanghai Fu Neng Biological Technology Co., Ltd., Shanghai 200237, P.R. China.

Articles cited by this

Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol (2010) 24.32

Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 19.61

MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene (2003) 7.90

Long noncoding RNAs and human disease. Trends Cell Biol (2011) 7.59

The epidemiology of cholangiocarcinoma. Semin Liver Dis (2004) 5.59

Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol (2004) 4.39

Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol (2011) 3.24

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg (2008) 3.16

Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest (2012) 2.56

Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog (2011) 2.53

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology (2013) 2.42

Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Invest (2012) 2.26

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol (2000) 2.25

Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) (2008) 2.04

Decreased expression of long noncoding RNA AC096655.1-002 in gastric cancer and its clinical significance. Tumour Biol (2013) 1.76

Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis (2012) 1.70

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol (2014) 1.67

The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol (2009) 1.58

Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology (2012) 1.57

Regulation of enzymes of urea and arginine synthesis. Annu Rev Nutr (1992) 1.49

Mining mammalian transcript data for functional long non-coding RNAs. PLoS One (2010) 1.46

Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol (2009) 1.40

Surgical management of intrahepatic cholangiocarcinoma--a population-based study. Ann Surg Oncol (2007) 1.39

Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma. Ann Surg Oncol (2007) 1.12

Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med Oncol (2013) 1.09

Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol (2008) 1.07

DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma. Am J Pathol (2011) 1.02

Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J Hepatol (2008) 1.00

Roles of Long Non-Coding RNAs on Tumorigenesis and Glioma Development. Brain Tumor Res Treat (2014) 0.99

Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis. Anticancer Res (2010) 0.97

Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery (2009) 0.97

The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population. Exp Mol Pathol (2010) 0.94

Multi-disciplinary treatment for cholangiocellular carcinoma. World J Gastroenterol (2007) 0.89

Molecular studies on an ancient gene encoding for carbamoyl-phosphate synthetase. Clin Sci (Lond) (1993) 0.89

GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma. Neoplasia (2007) 0.87

Primate-specific RFPL1 gene controls cell-cycle progression through cyclin B1/Cdc2 degradation. Cell Death Differ (2010) 0.84

Carbamyl phosphate synthetase I. A novel marker for gastric carcinoma. Chin Med J (Engl) (1989) 0.84

Urea-cycle disorders as a paradigm for inborn errors of hepatocyte metabolism. Trends Mol Med (2002) 0.82

[6]-Shogaol inhibits melanogenesis in B16 mouse melanoma cells through activation of the ERK pathway. Acta Pharmacol Sin (2012) 0.82

5-Azacytidine suppresses the proliferation of pancreatic cancer cells by inhibiting the Wnt/β-catenin signaling pathway. Genet Mol Res (2014) 0.80

Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors. Cancer Genet (2014) 0.80

Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. PLoS One (2013) 0.76